Epoch Biodesign is thrilled to announce a groundbreaking funding milestone, raising $18,300,000 to further revolutionize the recycling industry through scientific and technological innovation. This significant investment is set to accelerate Epoch’s mission of unlocking circularity for the toughest-to-recycle materials by leveraging its cutting-edge biorecycling platform. In an era where sustainability and responsible waste management have become crucial, Epoch’s approach is both timely and transformative. The company’s AI-designed enzyme technology is at the heart of its process; these enzymes function at low temperatures to enable infinite recycling for mixed plastics and textiles that have long challenged conventional recycling methods.
With this fresh capital injection, Epoch Biodesign is poised to expand its research and development capabilities and scale its innovative platform to new markets. The funding will be instrumental in optimizing the core technology and boosting production capacity, facilitating the creation of sustainable outputs for a diverse array of industries including apparel, automotive, packaging, and beyond. This strategic investment not only supports the company’s vision of a circular economy but also underscores the growing recognition of biomolecular innovations in solving complex environmental challenges. By turning waste into valuable resources, Epoch is paving the way for industries to reduce their ecological footprint while tapping into new economic opportunities.
This funding round marks a critical turning point in Epoch’s journey, empowering the team to advance its technology further and demonstrate that environmental stewardship and economic growth can indeed go hand in hand. The company invites partners and industry leaders to join in this mission to reimagine recycling for a sustainable future.
.png&w=3840&q=75)